Literature DB >> 20460688

Chemical characteristics and hemostatic performances of ordered mesoporous calcium-doped silica xerogels.

Xiaohui Wu1, Jie Wei, Xun Lu, Yang Lv, Fangping Chen, Yanglan Zhang, Changsheng Liu.   

Abstract

A well-ordered mesoporous silicon dioxide calcium-doped xerogel (m-SXC) was synthesized by a sol–gel process. The in vitro bioactivity of the m-SXC was investigated by analyzing the apatite-forming ability in simulated body fluid (SBF) and MC3T3-E1 cell culture with materials, and the hemostatic activity of the m-SXC was determined by measuring the activated partial thromboplastin time (APTT) and prothrombin time (PT) in vitro. The results suggested that the m-SXC exhibited excellent in vitro bioactivity, with surface apatite formation for them-SXC containing 10 w% Ca (m-SXC10) exceeding that containing 5 w% Ca (n-SXC5) and 0% Ca (m-SXC0) at 7 days, and the cell response test (MTT assay) and cell morphology observation demonstrated that these materials were biocompatible with no obvious negative effects on cellular viability. Moreover, the m-SXC with a high surface area (m-SXC0: 489.9 m(2) g(-1), m-SXC5: 466.5 m2 g(-1), m-SXC10: 438.1 m(2) g(-1)) possessed good hemostatic property because it could absorb a large amount of water from the blood, which could concentrate the components of blood and reduce the clotting time. Furthermore, the addition of calcium in the m-SXC had significant effects on the clotting time, in which the APTT(m-SXC0: 8 s, m-SXC5: 7 s, m-SXC10: 6 s, respectively) and PT (m-SXC0: 16 s, m-SXC5:11 s, m-SXC10: 10 s, respectively) were shortened with the increase of Ca amounts in them-SXC, indicating that incorporation of Ca in the m-SXC could improve its hemostatic activity.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20460688     DOI: 10.1088/1748-6041/5/3/035006

Source DB:  PubMed          Journal:  Biomed Mater        ISSN: 1748-6041            Impact factor:   3.715


  4 in total

1.  Mesoporous bioactive glasses: structure characteristics, drug/growth factor delivery and bone regeneration application.

Authors:  Chengtie Wu; Jiang Chang
Journal:  Interface Focus       Date:  2012-03-21       Impact factor: 3.906

2.  Porcine liver injury model to assess tantalum-containing bioactive glass powders for hemostasis.

Authors:  Malvika Nagrath; Danielle Bince; Corwyn Rowsell; Deanna Polintan; Joao Rezende-Neto; Mark Towler
Journal:  J Mater Sci Mater Med       Date:  2022-06-07       Impact factor: 4.727

3.  Sustained release of VH and rhBMP-2 from nanoporous magnesium-zinc-silicon xerogels for osteomyelitis treatment and bone repair.

Authors:  Fengqian Li; Wen Wu; Li Xiang; Gan Weng; Hua Hong; Hong Jiang; Jun Qian
Journal:  Int J Nanomedicine       Date:  2015-06-22

4.  Degradability, bioactivity, and osteogenesis of biocomposite scaffolds of lithium-containing mesoporous bioglass and mPEG-PLGA-b-PLL copolymer.

Authors:  Yanrong Cai; Lieping Guo; Hongxing Shen; Xiaofei An; Hong Jiang; Fang Ji; Yunfei Niu
Journal:  Int J Nanomedicine       Date:  2015-06-24
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.